24-0232
Approve and authorize the Chairman to execute First Amendment to Master Agreement No. 23-289 with Drug Medi-Cal certified providers, to update agreement language including provider reporting requirements, contractor participation requirements, and updating fee reimbursement schedules, with no change to the term of July 1, 2023 through June 30, 2027; approve and authorize the Chairman to execute First Amendment to Master Agreement No. 23-290 with Drug Medi-Cal certified providers, to update agreement language including provider reporting requirements, contractor participation requirements, and updating fee reimbursement schedules, with no change to the term of July 1, 2023 through June 30, 2027; approve and authorize the Chairman to execute First Amendment to Master Agreement No. 23-291 with Drug Medi-Cal certified providers, to update agreement language including provider reporting requirements, contractor participation requirements, and updating fee reimbursement schedules, with no change to the term of July 1, 2023, through June 30, 2027; approve and authorize the Chairman to execute First Amendment to Master Agreement No. 23-292 with Drug Medi-Cal certified residential substance use disorder treatment providers, to update agreement language including provider reporting requirements and contractor participation requirements with no change to the term of July 1, 2023, through June 30, 2027, or compensation maximum of $27,353,032; approve and authorize the Chairman to execute First Amendment to Master Agreement No. 23-293 with Drug Medi-Cal certified providers, to update agreement language including provider reporting requirements, contractor participation requirements, and updating fee reimbursement schedules, with no change to the term of July 1, 2023, through June 30, 2027, or compensation maximum of $10,585,252; and, approve and authorize the Chairman to execute First Amendment to Master Agreement No. 23-294 with Drug Medi-Cal certified providers, to update agreement language including provider reporting requirements, contractor participation requirements, and updating fee reimbursement schedules, with no change to the term of July 1, 2023 through June 30, 2027, or compensation maximum of $11,027,632
What this record is
- Held by
- Drug Medi-Cal 2 records across this site
- Amount
- $27.4M
- Runs until
- June 30, 2027 303 days — goes back out to bid date quoted from the award document
- Type
- amendment
See everything else expiring in this field →
Read automatically from the title of the official record. The source document below is authoritative.
Drug Medi-Cal also holds
Approve and authorize the Chairman to execute Second Amendment to Master Agreement No. 23-291 with Drug Medi-Cal certified providers, to update fee re…- Committee
- Behavioral Health
- Requested by
- Behavioral Health
- Introduced
- February 27, 2024
- On agenda
- June 4, 2024
- Passed
- June 4, 2024
- Enactment no.
- Agreement No. 24-259, Agreement No. 24-260, Agreement No. 24-261, Agreement No. 24-262, Agreement No. 24-263, Agreement No. 24-264